EpimAb Biotherapeutics announced Wednesday that it has raised $74 million in its Series B funding, extending the streak of private fundraising among Chinese biopharmaceutical firms specialising in anti-cancer drug research.
Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.
Note: This free trial is a one-time offer.
Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.
